Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis

American Journal of Pathology

Volumn 161, Issue 2, 2002, Pages 459-470

  Bonner, James C ^a   Rice, Annette B ^a   Ingram, Jennifer L ^a   Moomaw, Cindy R ^a   Nyska, Abraham ^a   Bradbury, Alyce ^a   Sessoms, Alisha R ^a   Chulada, Patricia C ^a   Morgan, Daniel L ^a   Zeldin, Darryl C ^a   Langenbach, Robert ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E2; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; VANADIUM PENTOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CLARA CELL; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROSIS; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

EID: 0036965875     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64202-2     Document Type: Article

References (31)

1. Smith WL, Dewitt DL: Prostaglandin endoperoxidase H synthases-1 and -2. Adv Immunol 1996, 62:167-215
2. Gavett SH, Madison SL, Scarborough PE, Qu W, Boyle JE, Chulada PC, Tiano HF, Lee CA, Langenbach R, Roggli VL, Zeldin DC: Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J Clin Invest 1999, 104:721-732
3. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters-Golden M: Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 1995, 95:1861-1868
4. Vancheri C, Sortino MA, Tomaselli V, Mastruzzo C, Condorelli F, Bellistri G, Pisterio MP, Canonico PL, Crimi N: Different expression of TNF-α receptors and prostaglandin-E2 production in normal and fibrotic lung fibroblasts. Am J Respir Cell Mol Biol 2000, 22:628-634
5. 2 counteracts interleukin-1β-stimulated up-regulation of platelet-derived growth factor a-receptor on rat pulmonary myofibroblasts. Am J Respir Cell Mol Biol 1999, 20:433-440
6. 2 on the activation of lung fibroblasts. Prostaglandins 1987, 33:903-913
7. 2. Am J Physiol 1999, 277:L1165-L1171
8. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Sim HS, Smithies O: Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995, 83:483-492
9. Morham SG, Langenbach RL, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, Smithies O: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995, 83:473-482
10. Langenbach R, Loftin C, Lee C, Tiano H: Cyclooxygenase knockout mice: models for elucidating isoform specific functions. Biochem Pharmacol 1999, 15:1237-1246
11. Levy BS, Hoffman L, Gottsegen S: Boilermaker's bronchitis: respiratory tract irritation associated with vanadium pentoxide exposure during oil-to-coal conversion of a power plant. J Occup Med 1984, 26:567-570
12. Bonner JC, Rice AB, Moomaw CR, Morgan DL: Airway fibrosis in rats induced by vanadium pentoxide. Am J Physiol 2000, 278:L209-L216
13. Bonner JC, Lindroos PM, Rice AB, Moomaw CR, Morgan DL: Induction of PDGF receptor-α in rat myofibroblasts during pulmonary fibrogenesis in vivo. Am J Physiol 1998, 274:L72-L80
14. Cherniack RM, Colby TV, Flint A, Thurlbeck WN, Waldron J, Ackerson L, King Jr TE: Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991, 144:892-900
15. Rice AB, Moomaw CR, Morgan DL, Bonner JC: Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am J Pathol 1999, 155:213-221
16. Chulada PC, Loftin CD, Winn VD, Young DA, Tiano HF, Eling TE, Langenbach R: Relative activities of retrovirally expressed murine prostaglandin synthase-1 and -2 depend on source of arachidonic acid. Arch Biochem Biophys 1996, 330:301-313
17. Morteau O, Morham SG, Sellon R, Dieleman LA, Langenbach R, Smithies O, Sartor RB: Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest 2000, 105:469-478
18. Zeldin DC, Wohlford-Lenane C, Chulada P, Bradbury JA, Scarborough PE, Roggli V, Langenbach R, Schwartz DA: Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2001, 25:457-465
19. Brock TG, McNish RW, Peters-Golden M: Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin-E2. J Biol Chem 1999, 274:11660-11666
20. Ogushi F, Endo T, Tani K, Asada K, Kawano T, Tada H, Maniwa K, Sone S: Decreased prostaglandin E2 synthesis by lung fibroblasts isolated from rats with bleomycin-induced lung fibrosis. Int J Exp Pathol 1999, 80:41-49
21. Piguet PF, Collart MA, Grau GE, Sappino A-P, Vassalli P: Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990, 344:245-247
22. Sime PJ, Marr RA, Gauldie D, Xing Z, Hewlett BR, Graham FL, Gauldie J: Transfer of tumor necrosis factor-α to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-β1 and myofibroblasts. Am J Pathol 1998, 153:825-832
23. Thrall RS, Vogel SN, Evans R, Shultz LD: Role of tumor necrosis factor-α in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. Am J Pathol 1997, 151:1303-1310
24. Liu J-Y, Brass DM, Hoyle GW, Brody AR: TNF-α receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 1998, 153:1839-1847
25. 2 production in murine macrophages. J Biol Chem 1997, 272:31065-31072
26. 2 J Lipid Med 1993, 6:175-181
27. D'Acquisto F, Sautebin L, Iuvone T, Di Rosa M, Carnuccio R: Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-κB activation in J774 macrophages. FEBS Lett 1998, 27:76-80
28. Ye J, Ding M, Zhang X, Rojanasakul Y, Nedospasov S, Vallyathan V, Castranova V, Shi X: Induction of TNF-α in macrophages by vanadate is dependent on activation of transcription factor NF-κB and free radical reactions. Mol Cell Biochem 1999, 198:193-200
29. Keerthisingam CB, Jenkins RG, Harrison NK, Hernandez-Rodriquez NA, Booth H, Laurent GJ, Hart SL, Foster ML, McAnulty RJ: Cyclooxygenase-2 deficiency results in a loss of the anti- proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 2001, 158:1411-1422
30. Peebles Jr RS, Dworski R, Collins RD, Jarzecka K, Mitchell DB, Graham BS, Sheller JR: Cyclooxygenase inhibition increases interleukin-5 and interleukin-13 production and airway hyper-responsiveness in al]ergic mice. Am J Respir Crit Care Med 2000, 162:676-681
31. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD: Interleukin-13: central mediator of allergic asthma. Science 1998, 282:2258-2261